Logo image of VSEE

VSEE HEALTH INC (VSEE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VSEE - US92919Y1029 - Common Stock

0.4139 USD
+0.02 (+3.94%)
Last: 1/13/2026, 8:00:02 PM
0.413 USD
0 (-0.22%)
Pre-Market: 1/14/2026, 6:19:40 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VSEE. VSEE was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of VSEE have multiple concerns. VSEE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VSEE has reported negative net income.
  • In the past year VSEE has reported a negative cash flow from operations.
  • VSEE had negative earnings in each of the past 5 years.
  • In the past 5 years VSEE always reported negative operating cash flow.
VSEE Yearly Net Income VS EBIT VS OCF VS FCFVSEE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • With a Return On Assets value of -66.71%, VSEE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -66.71%
ROE N/A
ROIC N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSEE Yearly ROA, ROE, ROICVSEE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100K 200K 300K

1.3 Margins

  • Looking at the Gross Margin, with a value of 54.64%, VSEE is doing worse than 60.00% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for VSEE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSEE Yearly Profit, Operating, Gross MarginsVSEE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

  • VSEE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VSEE has more shares outstanding than it did 1 year ago.
  • VSEE has a better debt/assets ratio than last year.
VSEE Yearly Shares OutstandingVSEE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
VSEE Yearly Total Debt VS Total AssetsVSEE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • VSEE has an Altman-Z score of -7.38. This is a bad value and indicates that VSEE is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -7.38, VSEE is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.38
ROIC/WACCN/A
WACC8.71%
VSEE Yearly LT Debt VS Equity VS FCFVSEE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • VSEE has a Current Ratio of 0.16. This is a bad value and indicates that VSEE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VSEE's Current ratio of 0.16 is on the low side compared to the rest of the industry. VSEE is outperformed by 97.14% of its industry peers.
  • VSEE has a Quick Ratio of 0.16. This is a bad value and indicates that VSEE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.16, VSEE is not doing good in the industry: 97.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
VSEE Yearly Current Assets VS Current LiabilitesVSEE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

  • VSEE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.57%, which is quite impressive.
  • VSEE shows a strong growth in Revenue. In the last year, the Revenue has grown by 121.76%.
EPS 1Y (TTM)77.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.49%
Revenue 1Y (TTM)121.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.67%

3.2 Future

  • The Earnings Per Share is expected to decrease by -182.84% on average over the next years. This is quite bad
  • Based on estimates for the next years, VSEE will show a very strong growth in Revenue. The Revenue will grow by 46.40% on average per year.
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

VSEE Yearly Revenue VS EstimatesVSEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 5M 10M 15M 20M
VSEE Yearly EPS VS EstimatesVSEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • VSEE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VSEE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSEE Price Earnings VS Forward Price EarningsVSEE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSEE Per share dataVSEE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5

4.3 Compensation for Growth

  • VSEE's earnings are expected to decrease with -182.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-182.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for VSEE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

VSEE HEALTH INC

NASDAQ:VSEE (1/13/2026, 8:00:02 PM)

Premarket: 0.413 0 (-0.22%)

0.4139

+0.02 (+3.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners3.36%
Inst Owner Change0%
Ins Owners16.1%
Ins Owner Change0%
Market Cap12.98M
Revenue(TTM)14.55M
Net Income(TTM)-12.48M
Analysts82.86
Price Target5.1 (1132.18%)
Short Float %3.23%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.1%
Min Revenue beat(2)-18.49%
Max Revenue beat(2)-7.7%
Revenue beat(4)1
Avg Revenue beat(4)-8.99%
Min Revenue beat(4)-18.49%
Max Revenue beat(4)7.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS0.46
BVpS-0.18
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.64%
FCFM N/A
ROA(3y)-266.08%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.07%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z -7.38
F-Score3
WACC8.71%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.49%
EPS Next Y-1100%
EPS Next 2Y-182.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)121.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.67%
Revenue Next Year64.83%
Revenue Next 2Y46.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-159.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-244.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-242.52%
OCF growth 3YN/A
OCF growth 5YN/A

VSEE HEALTH INC / VSEE FAQ

What is the fundamental rating for VSEE stock?

ChartMill assigns a fundamental rating of 1 / 10 to VSEE.


What is the valuation status of VSEE HEALTH INC (VSEE) stock?

ChartMill assigns a valuation rating of 0 / 10 to VSEE HEALTH INC (VSEE). This can be considered as Overvalued.


What is the profitability of VSEE stock?

VSEE HEALTH INC (VSEE) has a profitability rating of 0 / 10.


What is the earnings growth outlook for VSEE HEALTH INC?

The Earnings per Share (EPS) of VSEE HEALTH INC (VSEE) is expected to decline by -1100% in the next year.